The Impact of the Pharmaceutical Care Management Model of Hepatitis C Medications on the Cost at Health Insurance Level

MLA

Almahdi, Fadia B., et al. “The Impact of the Pharmaceutical Care Management Model of Hepatitis C Medications on the Cost at Health Insurance Level.” Value in Health Regional Issues, vol. 21, no. 1, May 2020, pp. 230–37. EBSCOhost, https://doi.org/10.1016/j.vhri.2020.01.004.

APA

Almahdi, F. B., Hashim, A. H., Albaba, E. A. M., Salih, O. N., Alkasam, R. J., Mosli, M. H., & Alsulaimani, A. F. (2020). The Impact of the Pharmaceutical Care Management Model of Hepatitis C Medications on the Cost at Health Insurance Level. Value in Health Regional Issues, 21(1), 230–237. https://doi.org/10.1016/j.vhri.2020.01.004

Chicago

Almahdi, Fadia B., Almoutaz H. Hashim, Emad Aldin M. Albaba, Ohoud N. Salih, Reem J. Alkasam, Mahmoud H. Mosli, and Ayman F. Alsulaimani. 2020. “The Impact of the Pharmaceutical Care Management Model of Hepatitis C Medications on the Cost at Health Insurance Level.” Value in Health Regional Issues 21 (1): 230–37. doi:10.1016/j.vhri.2020.01.004.